Advanced Enzyme [ADVENZYMES] vs Bhagiradha Chemicals [BHAGCHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Advanced Enzyme Technologies Ltd. wins in 18 metrics, Bhagiradha Chemicals & Industries Limited wins in 2 metrics, with 0 ties. Advanced Enzyme Technologies Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Advanced Enzyme Technologies Ltd. | Bhagiradha Chemicals & Industries Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.00 | 256.72 | Advanced Enzyme Technologies Ltd. |
| Price-to-Book Ratio | 2.26 | 4.93 | Advanced Enzyme Technologies Ltd. |
| Debt-to-Equity Ratio | 2.26 | 27.38 | Advanced Enzyme Technologies Ltd. |
| PEG Ratio | 1.68 | 10.42 | Advanced Enzyme Technologies Ltd. |
| EV/EBITDA | 14.17 | 81.35 | Advanced Enzyme Technologies Ltd. |
| Profit Margin (TTM) | 21.46% | 2.64% | Advanced Enzyme Technologies Ltd. |
| Operating Margin (TTM) | 22.76% | 7.72% | Advanced Enzyme Technologies Ltd. |
| EBITDA Margin (TTM) | 22.76% | 7.72% | Advanced Enzyme Technologies Ltd. |
| Return on Equity | 8.93% | 2.03% | Advanced Enzyme Technologies Ltd. |
| Return on Assets (TTM) | 8.09% | 1.48% | Advanced Enzyme Technologies Ltd. |
| Free Cash Flow (TTM) | $1.08B | $-3.05B | Advanced Enzyme Technologies Ltd. |
| Dividend Yield | 1.56% | 0.03% | Advanced Enzyme Technologies Ltd. |
| 1-Year Return | 15.08% | -11.67% | Advanced Enzyme Technologies Ltd. |
| Price-to-Sales Ratio (TTM) | 4.72 | 6.72 | Advanced Enzyme Technologies Ltd. |
| Enterprise Value | $28.07B | $34.99B | Bhagiradha Chemicals & Industries Limited |
| EV/Revenue Ratio | 3.96 | 6.99 | Advanced Enzyme Technologies Ltd. |
| Gross Profit Margin (TTM) | 75.92% | 42.97% | Advanced Enzyme Technologies Ltd. |
| Revenue per Share (TTM) | $63 | $39 | Advanced Enzyme Technologies Ltd. |
| Earnings per Share (Diluted) | $13.60 | $1.01 | Advanced Enzyme Technologies Ltd. |
| Beta (Stock Volatility) | 0.45 | 0.11 | Bhagiradha Chemicals & Industries Limited |
Advanced Enzyme Technologies Ltd. vs Bhagiradha Chemicals & Industries Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Ltd. | -0.43% | -1.25% | 0.99% | 33.36% | 17.44% | 20.82% |
| Bhagiradha Chemicals & Industries Limited | -3.69% | 10.75% | 4.43% | 38.51% | 13.73% | 26.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Ltd. | 15.08% | 34.80% | -11.33% | 29.55% | 29.55% | 29.55% |
| Bhagiradha Chemicals & Industries Limited | -11.67% | 71.91% | 291.14% | 291.14% | 291.14% | 291.14% |
Performance & Financial Health Analysis: Advanced Enzyme Technologies Ltd. vs Bhagiradha Chemicals & Industries Limited
| Metric | ADVENZYMES | BHAGCHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹33.43B | ₹33.62B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 171,022 | 241,686 |
| 90 Day Avg. Volume | 152,508 | 254,158 |
| Last Close | ₹367.35 | ₹260.08 |
| 52 Week Range | ₹251.95 - ₹419.00 | ₹170.60 - ₹325.00 |
| % from 52W High | -12.33% | -19.98% |
| All-Time High | ₹571.00 (Sep 16, 2024) | ₹1,999.00 (Apr 15, 2024) |
| % from All-Time High | -35.67% | -86.99% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.11% |
| Quarterly Earnings Growth | 0.13% | 0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.03% |
| Operating Margin (TTM) | 0.23% | 0.08% |
| Return on Equity (TTM) | 0.09% | 0.02% |
| Debt to Equity (MRQ) | 2.26 | 27.38 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹132.60 | ₹52.61 |
| Cash per Share (MRQ) | ₹54.16 | ₹1.10 |
| Operating Cash Flow (TTM) | ₹1.70B | ₹-833,035,000 |
| Levered Free Cash Flow (TTM) | ₹1.31B | ₹138.57M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.56% | 0.03% |
| Last 12-Month Dividend | ₹5.20 | ₹0.10 |
Valuation & Enterprise Metrics Analysis: Advanced Enzyme Technologies Ltd. vs Bhagiradha Chemicals & Industries Limited
| Metric | ADVENZYMES (Apr 24, 2026) | BHAGCHEM (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.00 | 256.72 |
| Forward P/E | 19.30 | N/A |
| PEG Ratio | 1.68 | 10.42 |
| Price to Sales (TTM) | 4.72 | 6.72 |
| Price to Book (MRQ) | 2.26 | 4.93 |
| Market Capitalization | ||
| Market Capitalization | ₹33.43B | ₹33.62B |
| Enterprise Value | ₹28.07B | ₹34.99B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.96 | 6.99 |
| Enterprise to EBITDA | 14.17 | 81.35 |
| Risk & Other Metrics | ||
| Beta | 0.45 | 0.11 |
| Book Value per Share (MRQ) | ₹132.60 | ₹52.61 |
Financial Statements Comparison: Advanced Enzyme Technologies Ltd. vs Bhagiradha Chemicals & Industries Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ADVENZYMES (2025) | BHAGCHEM (2025) |
|---|---|---|
| Revenue/Sales | 6.37B | 4.40B |
| Cost of Goods Sold | 1.65B | 3.46B |
| COGS % of Revenue | 25.9% | 78.5% |
| Gross Profit | 4.72B | 944.49M |
| Gross Margin | 74.1% | 21.5% |
| Research & Development | 8.75M | 30.20M |
| Operating Income (EBIT) | 1.61B | 232.37M |
| Operating Margin | 25.2% | 5.3% |
| EBITDA | 2.23B | 389.66M |
| EBITDA Margin | 35.0% | 8.8% |
| Pre-Tax Income | 1.87B | 252.50M |
| Pre-Tax Income % of Revenue | 29.4% | 5.7% |
| Income Tax | 533.90M | 113.92M |
| Income Tax % of Revenue | 8.4% | 2.6% |
| Net Income (Profit) | 1.34B | 138.57M |
| Profit Margin | 21.0% | 3.1% |
Balance Sheet & Liquidity Metrics
| Metric | ADVENZYMES (2025) | BHAGCHEM (2025) |
|---|---|---|
| Cash & Equivalents | 942.25M | 282.25M |
| Total Current Assets | 8.80B | 3.75B |
| Total Current Assets % of Revenue | 138.2% | 85.1% |
| Total Current Liabilities | 967.55M | 1.95B |
| Total Current Liabilities % of Revenue | 15.2% | 44.3% |
| Long-Term Debt | 209.17M | 332.79M |
| Long-Term Debt % of Revenue | 3.3% | 7.6% |
| Total Shareholders Equity | 14.69B | 6.82B |
| Retained Earnings | 11.53B | 1.86B |
| Retained Earnings % of Revenue | 181.2% | 42.3% |
| Property, Plant & Equipment | 2.93B | 297.13M |
Cash Flow Statement Comparison
| Metric | ADVENZYMES (2025) | BHAGCHEM (2025) |
|---|---|---|
| Operating Cash Flow | 1.70B | -833.04M |
| Operating Cash Flow % of Revenue | 26.7% | -18.9% |
| Capital Expenditures | -332.81M | -2.49B |
| Free Cash Flow | 1.08B | -3.05B |
| FCF Margin | 16.9% | -69.3% |
| Debt Repayment | -58.08M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ADVENZYMES | BHAGCHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 111.93M | 129.67M |
| Float Shares | 36.89M | 45.56M |
| % Held by Insiders | 55.52% | 64.27% |
| % Held by Institutions | 18.75% | 5.02% |
| % Held by Public | 25.73% | 30.71% |
Dividend Analysis & Yield Comparison: Advanced Enzyme Technologies Ltd. vs Bhagiradha Chemicals & Industries Limited
| Metric | ADVENZYMES | BHAGCHEM |
|---|---|---|
| Last 12-Month Dividend | ₹5.20 | ₹0.10 |
| Last 12-Month Dividend Yield | 1.56% | 0.03% |
| 3-Year Avg Annual Dividend | ₹5.43 | ₹0.05 |
| 3-Year Avg Dividend Yield | 0.75% | 0.01% |
| 3-Year Total Dividends | ₹16.30 | ₹0.16 |
| Ex-Dividend Date | Jul 23, 2025 | Aug 02, 2024 |